Go to
JCI Insight
Citations to this article
Wanda Kwan, … , Sarah J. Tabrizi, Paul J. Muchowski
Published November 19, 2012
Citation Information: J Clin Invest. 2012;122(12):4737-4747. https://doi.org/10.1172/JCI64484.
Citation Information: J Clin Invest. 2012;122(12):4737-4747. https://doi.org/10.1172/JCI64484.
Abstract
In Huntington disease (HD), immune cells are activated before symptoms arise; however, it is unclear how the expression of mutant huntingtin (htt) compromises the normal functions of immune cells. Here we report that primary microglia from early postnatal HD mice were profoundly impaired in their migration to chemotactic stimuli, and expression of a mutant htt fragment in microglial cell lines was sufficient to reproduce these deficits. Microglia expressing mutant htt had a retarded response to a laser-induced brain injury in vivo. Leukocyte recruitment was defective upon induction of peritonitis in HD mice at early disease stages and was normalized upon genetic deletion of mutant htt in immune cells. Migration was also strongly impaired in peripheral immune cells from pre-manifest human HD patients. Defective actin remodeling in immune cells expressing mutant htt likely contributed to their migration deficit. Our results suggest that these functional changes may contribute to immune dysfunction and neurodegeneration in HD, and may have implications for other polyglutamine expansion diseases in which mutant proteins are ubiquitously expressed.
Authors
Wanda Kwan, Ulrike Träger, Dimitrios Davalos, Austin Chou, Jill Bouchard, Ralph Andre, Aaron Miller, Andreas Weiss, Flaviano Giorgini, Christine Cheah, Thomas Möller, Nephi Stella, Katerina Akassoglou, Sarah J. Tabrizi, Paul J. Muchowski
Total citations by year
Citation information
Citations to this article (84)
| Title and authors | Publication | Year |
|---|---|---|
|
The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy
Shehjar F, Almarghalani DA, Mahajan R, Hasan SA, Shah ZA |
Cells | 2024 |
|
Large animal models for Huntington’s disease research
Han B, Liang W, Li XJ, Li S, Yan S, Tu Z |
Zoological Research | 2024 |
|
Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases
Vohra A, Keefe P, Puthanveetil P |
Metabolites | 2024 |
|
Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models.
Cvetanovic M, Gray M |
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023 |
|
A Brief Overview of Neutrophils in Neurological Diseases
Chakraborty S, Tabrizi Z, Bhatt NN, Franciosa SA, Bracko O |
Biomolecules | 2023 |
|
Innate immune activation and aberrant function in the R6/2 mouse model and Huntington’s disease iPSC-derived microglia
Gasser J, Gillet G, Valadas JS, Rouvière L, Kotian A, Fan W, Keaney J, Kadiu I |
Frontiers in molecular neuroscience | 2023 |
|
Pain in Huntington's disease and its potential mechanisms.
Li J, Wang Y, Yang R, Ma W, Yan J, Li Y, Chen G, Pan J |
Frontiers in aging neuroscience | 2023 |
|
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Bhat SA, Ahamad S, Dar NJ, Siddique YH, Nazir A |
Current neuropharmacology | 2023 |
|
Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.
Wilton DK, Mastro K, Heller MD, Gergits FW, Willing CR, Fahey JB, Frouin A, Daggett A, Gu X, Kim YA, Faull RLM, Jayadev S, Yednock T, Yang XW, Stevens B |
Nature Medicine | 2023 |
|
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z, Manzoni C, Zarkali A, Durr A, Roos RA, Landwehrmeyer B, Leavitt BR, Rees G, Tabrizi SJ, McColgan P |
Brain : a journal of neurology | 2023 |
|
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
Ma YM, Zhao L |
Behavioural neurology | 2023 |
|
Anti-inflammatory role of GM1 and other gangliosides on microglia
D Galleguillos, Q Wang, N Steinberg, A Zaidi, G Shrivastava, K Dhami, G Daskhan, E Schmidt, Z Dworsky-Fried, F Giuliani, M Churchward, C Power, K Todd, A Taylor, M Macauley, S Sipione |
Journal of Neuroinflammation | 2022 |
|
The role of efferocytosis in neuro-degenerative diseases
F Taheri, E Taghizadeh, J Navashenaq, M Rezaee, S Gheibihayat |
Neurological Sciences | 2022 |
|
Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease.
Lee HN, Hyeon SJ, Kim H, Sim KM, Kim Y, Ju J, Lee J, Wang Y, Ryu H, Seong J |
Acta Neuropathologica | 2022 |
|
Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
Swaih AM, Breda C, Sathyasaikumar KV, Allcock N, Collier MEW, Mason RP, Feasby A, Herrera F, Outeiro TF, Schwarcz R, Repici M, Giorgini F |
Biomedicines | 2022 |
|
Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
L Villegas, A Nørremølle, K Freude, F Vilhardt |
Frontiers in aging neuroscience | 2021 |
|
Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species
GC ORegan, SH Farag, CS Casey, A Wood-Kaczmar, JM Pocock, SJ Tabrizi, R Andre |
Journal of Neuroinflammation | 2021 |
|
What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
L Przybyl, M Wozna-Wysocka, E Kozlowska, A Fiszer |
International journal of molecular sciences | 2021 |
|
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
TE Phillips, E Maguire |
Frontiers in cellular neuroscience | 2021 |
|
Microbiota‐Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling
L Boeri, S Perottoni, L Izzo, C Giordano, D Albani |
Advanced Healthcare Materials | 2021 |
|
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
F Novellino, V Saccà, A Donato, P Zaffino, MF Spadea, M Vismara, B Arcidiacono, N Malara, I Presta, G Donato |
International journal of molecular sciences | 2020 |
|
Immune dysregulation in depression: Evidence from genome-wide association
JD Tubbs, J Ding, L Baum, PC Sham |
2020 | |
|
Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
M Gavriilaki, VK Kimiskidis, E Gavriilaki |
Pharmaceuticals (Basel, Switzerland) | 2020 |
|
RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease
MA Andrade-Navarro, K Mühlenberg, EJ Spruth, N Mah, A González-López, T Andreani, J Russ, MR Huska, EM Muro, JF Fontaine, V Amstislavskiy, A Soldatov, W Nietfeld, EE Wanker, J Priller |
Frontiers in neurology | 2020 |
|
The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase
RN Seervai, RK Jangid, M Karki, DN Tripathi, SY Jung, SE Kearns, KJ Verhey, MA Cianfrocco, BA Millis, MJ Tyska, FM Mason, WK Rathmell, IY Park, R Dere, CL Walker |
Science Advances | 2020 |
|
Wild-type huntingtin regulates human macrophage function
GC ORegan, SH Farag, GR Ostroff, SJ Tabrizi, R Andre |
Scientific Reports | 2020 |
|
The contribution of glial cells to Huntington's disease pathogenesis
DK Wilton, B Stevens |
Neurobiology of Disease | 2020 |
|
Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
A Kim, E García-García, M Straccia, A Comella-Bolla, A Miguez, M Masana, J Alberch, JM Canals, MJ Rodríguez |
Frontiers in cellular neuroscience | 2020 |
|
The Emerging Roles of Ferroptosis in Huntington’s Disease
Y Mi, X Gao, H Xu, Y Cui, Y Zhang, X Gou |
NeuroMolecular Medicine | 2019 |
|
Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
VL DiBona, W Zhu, MK Shah, A Rafalia, HB Cheikh, DP Crockett, H Zhang |
Journal of Neuroinflammation | 2019 |
|
iNKT Cell Activation Exacerbates the Development of Huntington’s Disease in R6/2 Transgenic Mice
HJ Park, SW Lee, W Im, M Kim, LV Kaer, S Hong |
Mediators of Inflammation | 2019 |
|
Huntingtin associates with the actin cytoskeleton and α-actinin isoforms to influence stimulus dependent morphology changes
A Tousley, M Iuliano, E Weisman, E Sapp, H Richardson, P Vodicka, J Alexander, N Aronin, M DiFiglia, KB Kegel-Gleason, F Saudou |
PloS one | 2019 |
|
Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
L Yu-Taeger, J Stricker-Shaver, K Arnold, P Bambynek-Dziuk, A Novati, E Singer, A Lourhmati, C Fabian, J Magg, O Riess, M Schwab, A Stolzing, L Danielyan, HH Nguyen |
Cells | 2019 |
|
Expression of Human Mutant Huntingtin Protein in Drosophila Hemocytes Impairs Immune Responses
YH Lin, HO Maaroufi, E Ibrahim, L Kucerova, M Zurovec |
Frontiers in immunology | 2019 |
|
Calmodulin‐mediated events during the life cycle of the amoebozoan Dictyostelium discoideum
DH O'Day, S Mathavarajah, MA Myre, RJ Huber |
Biological reviews of the Cambridge Philosophical Society | 2019 |
|
CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
AC Bolla, T Valente, A Miguez, V Brito, S Gines, C Solà, M Straccia, JM Canals, SD Ginsberg |
PloS one | 2019 |
|
Macrophages
G Rousselet |
Macrophages | 2018 |
|
Therapeutic approaches to Huntington disease: from the bench to the clinic
NS Caron, ER Dorsey, MR Hayden |
Nature Reviews Drug Discovery | 2018 |
|
Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
AU Joshi, D Mochly-Rosen |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2018 |
|
Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
A Labadorf, SH Choi, RH Myers |
Frontiers in molecular neuroscience | 2018 |
|
New tricks for an ancient system: Physiological and pathological roles of complement in the CNS
AJ Tenner, B Stevens, TM Woodruff |
Molecular Immunology | 2018 |
|
Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice
SW Lee, HJ Park, W Im, M Kim, S Hong |
Animal Cells and Systems | 2018 |
|
Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis
X Dong, S Cong |
Molecular medicine reports | 2018 |
|
Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington’s Disease
A Tousley, M Iuliano, E Weisman, E Sapp, N Zhang, P Vodicka, J Alexander, H Aviolat, L Gatune, P Reeves, X Li, A Khvorova, ML Ellerby, N Aronin, M DiFiglia, BK Kegel-Gleason |
Journal of Huntington's disease | 2018 |
|
Cofilin Mediates LPS-Induced Microglial Cell Activation and Associated Neurotoxicity Through Activation of NF-κB and JAK–STAT Pathway
Q Alhadidi, ZA Shah |
Molecular Neurobiology | 2017 |
|
Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease
DJ Moss, MD Flower, KK Lo, JR Miller, GJ van Ommen, PA Hoen, TC Stone, A Guinee, DR Langbehn, L Jones, V Plagnol, WM van Roon-Mom, P Holmans, SJ Tabrizi |
Scientific Reports | 2017 |
|
The dynamics of early-state transcriptional changes and aggregate formation in a Huntington’s disease cell model
M Hagen, DG Piebes, WC de Leeuw, IM Vuist, WM van Roon-Mom, PD Moerland, PJ Verschure |
BMC Genomics | 2017 |
|
Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts
P Jędrak, M Krygier, K Tońska, M Drozd, M Kaliszewska, E Bartnik, W Sołtan, EJ Sitek, A Stanisławska-Sachadyn, J Limon, J Sławek, G Węgrzyn, S Barańska |
Metabolic Brain Disease | 2017 |
|
Age-associated chromatin relaxation is enhanced in Huntington’s disease mice
M Park, B Min, K Jeon, S Cho, JS Park, J Kim, J Jeon, J Song, S Kim, S Jeong, H Seo, YK Kang |
Aging | 2017 |
|
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
M Alpaugh, D Galleguillos, J Forero, LC Morales, SW Lackey, P Kar, AD Pardo, A Holt, BJ Kerr, KG Todd, GB Baker, K Fouad, S Sipione |
EMBO Molecular Medicine | 2017 |
|
Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays
DJ Moss, N Robertson, R Farmer, RI Scahill, S Haider, MA Tessari, G Flynn, DF Fischer, EJ Wild, D Macdonald, SJ Tabrizi, DR Borchelt |
PloS one | 2017 |
|
A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses
J Zha, X Liu, J Zhu, S Liu, S Lu, P Xu, X Yu, R Liu |
Scientific Reports | 2016 |
|
Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific: Huntington Aggregation in Neurons and Glia
AH Jansen, M Hal, IC Kelder, RT Meier, AA Ruiter, MH Schut, DL Smith, C Grit, N Brouwer, W Kamphuis, HW Boddeke, WF Dunnen, WM van Roon, GP Bates, EM Hol, EA Reits |
Glia | 2016 |
|
Neuroimmunology of Huntington’s Disease: Revisiting Evidence from Human Studies
NP Rocha, FM Ribeiro, E Furr-Stimming, AL Teixeira |
Mediators of Inflammation | 2016 |
|
RNA-Seq of Huntington’s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation
JR Miller, KK Lo, R Andre, DJ Moss, U Träger, TC Stone, L Jones, P Holmans, V Plagnol, SJ Tabrizi |
Human Molecular Genetics | 2016 |
|
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
M Garcia-Miralles, X Hong, LJ Tan, NS Caron, Y Huang, XV To, RY Lin, S Franciosi, S Papapetropoulos, L Hayardeny, MR Hayden, KH Chuang, MA Pouladi |
Scientific Reports | 2016 |
|
iPSC-based drug screening for Huntington׳s disease
N Zhang, BJ Bailus, KL Ring, LM Ellerby |
Brain Research | 2016 |
|
αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease
AO Oliveira, A Osmand, TF Outeiro, PJ Muchowski, S Finkbeiner |
Human Molecular Genetics | 2016 |
|
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
L Dobson, U Träger, R Farmer, L Hayardeny, P Loupe, MR Hayden, SJ Tabrizi |
Journal of Neurochemistry | 2016 |
|
Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells
A Speidel, S Felk, P Reinhardt, J Sterneckert, F Gillardon, E Greggio |
PloS one | 2016 |
|
Huntington’s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
M Jimenez-Sanchez, F Licitra, BR Underwood, DC Rubinsztein |
Cold Spring Harbor Perspectives in Medicine | 2016 |
|
Huntington’s Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways
G Melkani |
Reactive Oxygen Species | 2016 |
|
Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington’s Disease T Lymphocytes
JR Miller, U Träger, R Andre, SJ Tabrizi, DR Borchelt |
PloS one | 2015 |
|
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
U Träger, R Andre, A Magnusson-Lind, JR Miller, C Connolly, A Weiss, S Grueninger, E Silajdžić, DL Smith, BR Leavitt, GP Bates, M Björkqvist, SJ Tabrizi |
Neurobiology of Disease | 2015 |
|
The Role of the Immune System in Triplet Repeat Expansion Diseases
M Olejniczak, MO Urbanek, WJ Krzyzosiak |
Mediators of Inflammation | 2015 |
|
The choreography of neuroinflammation in Huntington's disease
A Crotti, CK Glass |
Trends in Immunology | 2015 |
|
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
I Choi, B Kim, JW Byun, SH Baik, YH Huh, JH Kim, I Mook-Jung, WK Song, JH Shin, H Seo, YH Suh, I Jou, SM Park, HC Kang, EH Joe |
Nature Communications | 2015 |
|
The Potential Regulatory Mechanisms of miR-196a in Huntington’s Disease through Bioinformatic Analyses
MH Fu, CL Li, HL Lin, SJ Tsai, YY Lai, YF Chang, PH Cheng, CM Chen, SH Yang, J Zhang |
PloS one | 2015 |
|
Transcriptional dysregulation of inflammatory/immune pathways after active vaccination against Huntington′s disease
AI Ramsingh, K Manley, Y Rong, A Reilly, A Messer |
Human Molecular Genetics | 2015 |
|
Safety of Striatal Infusion of siRNA in a Transgenic Huntington’s Disease Mouse Model
E Johnson, K Chase, S McGowan, E Mondo, E Pfister, E Mick, RH Friedline, JK Kim, E Sapp, M DiFiglia, N Aronin |
Journal of Huntington's disease | 2015 |
|
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF B pathway dysregulation
U Trager, R Andre, N Lahiri, A Magnusson-Lind, A Weiss, S Grueninger, C McKinnon, E Sirinathsinghji, S Kahlon, EL Pfister, R Moser, H Hummerich, M Antoniou, GP Bates, R Luthi-Carter, MW Lowdell, M Bjorkqvist, GR Ostroff, N Aronin, SJ Tabrizi |
Brain | 2014 |
|
Innate immune activation in neurodegenerative disease
MT Heneka, MP Kummer, E Latz |
Nature Reviews Immunology | 2014 |
|
AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease
LT Alto, X Chen, KA Ruhn, I Treviño, MG Tansey |
PloS one | 2014 |
|
Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System
J Janssens, H Etienne, S Idriss, A Azmi, B Martin, S Maudsley |
Frontiers in Endocrinology | 2014 |
|
The ubiquitin proteasome system in glia and its role in neurodegenerative diseases
AH Jansen, EA Reits, EM Hol |
Frontiers in molecular neuroscience | 2014 |
|
The Differential Profiling of Ubiquitin-Proteasome and Autophagy Systems in Different Tissues before the Onset of Huntington's Disease Models: Protein Clearance Pathways in Huntington's Disease
LS Her, JY Lin, MH Fu, YF Chang, CL Li, TY Tang, YL Jhang, CY Chang, MC Shih, PH Cheng, SH Yang |
Brain Pathology | 2014 |
|
Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease
AD Pardo, S Alberti, V Maglione, E Amico, EP Cortes, F Elifani, G Battaglia, CL Busceti, F Nicoletti, JP Vonsattel, F Squitieri |
Molecular brain | 2013 |
|
Towards a ‘systems’-level understanding of the nervous system and its disorders
IA Qureshi, MF Mehler |
Trends in Neurosciences | 2013 |
|
A multifunctional, multi-pathway intracellular localization signal in Huntingtin
CR Desmond, T Maiuri, R Truant |
Communicative & integrative biology | 2013 |
|
The role of the immune system in Huntington's disease
G Ellrichmann, C Reick, C Saft, RA Linker |
Clinical & developmental immunology | 2013 |
|
Caveolin isoform switching as a molecular, structural, and metabolic regulator of microglia
IR Niesman, N Zemke, HN Fridolfsson, KJ Haushalter, K Levy, A Grove, R Schnoor, JC Finley, PM Patel, DM Roth, BP Head, HH Patel |
Molecular and Cellular Neuroscience | 2013 |
|
Choosing an animal model for the study of Huntington's disease
MA Pouladi, AJ Morton, MR Hayden |
Nature Reviews Neuroscience | 2013 |
|
Correlation of cytokine levels and microglial cell infiltration during retinal degeneration in RCS rats
Y Liu, X Yang, TP Utheim, C Guo, M Xiao, Y Liu, Z Yin, J Ma |
PloS one | 2013 |
|
Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys
J Kocerha, Y Liu, D Willoughby, K Chidamparam, J Benito, K Nelson, Y Xu, T Chi, H Engelhardt, S Moran, SH Yang, SH Li, XJ Li, K Larkin, A Neumann, H Banta, JJ Yang, AW Chan |
BMC neuroscience | 2013 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)